Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Moon Kyung Joo, Jong Eun Yeon, Ji Hoon Kim, Young Kul Jung, Sun Jae Lee, Jeong Han Kim, Hyung Joon Yim, Kwan Soo Byun, Jong-Jae Park, Jae Seon Kim & Young-Tae Bak. (2008) Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment. Scandinavian Journal of Gastroenterology 43:12, pages 1514-1521.
Read now
Read now
Articles from other publishers (49)
Carla S. Coffin, Scott K. Fung, Fernando Alvarez, Curtis L. Cooper, Karen E. Doucette, Claire Fournier, Erin Kelly, Hin Hin Ko, Mang M Ma, Steven R Martin, Carla Osiowy, Alnoor Ramji, Edward Tam & Jean Pierre Villeneuve. (2018) Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. Canadian Liver Journal 1:4, pages 156-217.
Crossref
Crossref
Ali Karimi, Loghman Salimzadeh & Nader Bagheri. (2014) Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran. Jundishapur Journal of Microbiology 7:5.
Crossref
Crossref
Hong Peng, Junying Liu, Min Yang, Shiwen Tong, Wenwei Yin, Hui Tang, Peng Hu, Huaidong Hu & Hong Ren. (2014) Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis. The Journal of Clinical Pharmacology 54:2, pages 189-200.
Crossref
Crossref
Feng Wu, Min-Jin Wu, Xiao-Lin Zhuge, Shao-Ming Zhu & Biao Zhu. (2012) Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment. Hepatobiliary & Pancreatic Diseases International 11:2, pages 172-176.
Crossref
Crossref
Chen Wei, Chong Yu-tian, Wen Ji-zhi, Li Yong-wei & Li Gang. (2011) Characterization of hepatitis virus B isolated from a multi-drug refractory patient. Virus Research 155:1, pages 254-258.
Crossref
Crossref
Stephen Locarnini & Fabien Zoulim. (2010) Molecular Genetics of HBV Infection. Antiviral Therapy 15:3_suppl, pages 3-14.
Crossref
Crossref
Ruth Chin, Ulrich Nachbur, Linda Earnest-Silveira, Aleksandra Bankovacki, Bernd Koeberlein, Hanswalter Zentgraf, C.-Thomas Bock, John Silke & Joseph Torresi. (2010) Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus. Virus Research 147:1, pages 7-16.
Crossref
Crossref
F. Ntziora, D. Paraskevis, C. Haida, E. Magiorkinis, E. Manesis, G. Papatheodoridis, S. Manolakopoulos, A. Beloukas, S. Chryssoy, G. Magiorkinis, V. Sypsa & A. Hatzakis. (2009) Quantitative Detection of the M204V Hepatitis B Virus Minor Variants by Amplification Refractory Mutation System Real-Time PCR Combined with Molecular Beacon Technology. Journal of Clinical Microbiology 47:8, pages 2544-2550.
Crossref
Crossref
S. Gloria Selabe, Ernest Song, Rosemary J. Burnett & M. Jeffrey Mphahlele. (2009) Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes. Journal of Medical Virology 81:6, pages 996-1001.
Crossref
Crossref
Richard A. HeipertzJr.Jr., Jason L. Starkey, Thomas G. Miller, Jianming Hu & Harriet C. Isom. (2009) trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase. Virology 388:1, pages 57-67.
Crossref
Crossref
Feifei Wang, Honghai Wang, Hongbo Shen, Chengyan Meng, Xinhua Weng & Wenhong Zhang. (2009) Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues. Clinical Therapeutics 31:2, pages 360-366.
Crossref
Crossref
Patrick TF Kennedy, Heather C Lee, Lukshmy Jeyalingam, Raza Malik, Peter Karayiannis, David Muir, Janice Main, Mark Thursz, Robert Goldin, Belinda Smith, Ashley Brown & Howard C Thomas. (2008) NICE Guidelines and a Treatment Algorithm for the Management of Chronic Hepatitis B: A Review of 12 Years Experience in West London. Antiviral Therapy 13:8, pages 1067-1076.
Crossref
Crossref
Reiichiro Kuwahara, Ryukichi Kumashiro, Tatsuya Ide, Yuriko Koga, Teruko Hino, Akiko Hisamochi, Kazuo Tanaka, Kei Ogata, Hiroyuki Koga, Yukari Takao & Michio Sata. (2008) Predictive Factors Associated with the Progression to Hepatic Failure Caused by Lamivudine-Resistant HBV. Digestive Diseases and Sciences 53:11, pages 2999-3006.
Crossref
Crossref
R. Orlando, G. Tosone, G. Portella, E. Veropalumbo, M. D’Onofrio & M. Piazza. (2007) Prolonged Persistence of Lamivudine-resistant Mutant and Emergence of New Lamivudine-resistant Mutants Two Years After Lamivudine Withdrawal in HBsAg-positive Chronic Hepatitis Patient: A Case Report. Infection 36:5, pages 472-474.
Crossref
Crossref
Bo Feng, Lai Wei, Ming Chen & Liping Wang. (2008) Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B. Microbiological Research 163:4, pages 487-492.
Crossref
Crossref
Kathryn L Nash & Graeme JM Alexander. (2008) The case for combination antiviral therapy for chronic hepatitis B virus infection. The Lancet Infectious Diseases 8:7, pages 444-448.
Crossref
Crossref
Jong-Kee Kim, Hyeon-Ji Lee, Young-Jo Lee, Jong-Yoon Chun, In-Kyoung Lee, Young-Suk Lim, Dong Jin Suh, Sun-Young Ko, Myeong Hee Kim & Heung-Bum Oh. (2008) Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers. Journal of Virological Methods 149:1, pages 76-84.
Crossref
Crossref
Wei-Zhen Xu. (2008) Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C. World Journal of Gastroenterology 14:23, pages 3733.
Crossref
Crossref
Marcelle Bottecchia, Nilo Ikuta, Christian Niel, Natalia M Araujo, Kycia MR Ó & Selma A Gomes. (2007) Lamivudine resistance and other mutations in the polymerase and surface antigen genes of hepatitis B virus associated with a fatal hepatic failure case. Journal of Gastroenterology and Hepatology 23:1, pages 67-72.
Crossref
Crossref
Makoto Nakamuta, Kazuhiro Kotoh, Munechika Enjoji, Eiji Kajiwara, Junya Shimono, Akihide Masumoto, Toshihiro Maruyama, Norihiro Furusyo, Hideyuki Nomura, Hironori Sakai, Kazuhiro Takahashi, Koichi Azuma, Shinji Shimoda, Yuichi Tanabe & Jun Hayashi. (2007) Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients. Comparative Hepatology 6:1.
Crossref
Crossref
Yi-Hao Yen, Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, Chun-Mei Wu, Chao-Hung Hung, Po-lin Tseng, Tsung-Hui Hu, Chi-Sin Changchien & Chuan-Mo Lee. (2007) Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non-seroconverted patients during lamivudine therapy. Liver International 27:10, pages 1349-1355.
Crossref
Crossref
X. P. Pan, L. J. Li, W. B. Du, M. W. Li, H. C. Cao & J. F. Sheng. (2007) Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C. Journal of Viral Hepatitis 14:11, pages 767-774.
Crossref
Crossref
Masaaki Takamura, Takafumi Ichida, Shogo Ohkoshi, Shunsuke Tsubata, Akihiko Osaki, Tomoya Aoyagi, Minoru Nomoto, Kazuhiro Uehara, Haruo Terada & Yutaka Aoyagi. (2007) Decompensated Lamivudine-resistant Hepatitis B Virus-related Cirrhosis Treated Successfully with Adefovir Dipivoxil Allowing Surgery for Hepatocellular Carcinoma. Internal Medicine 46:7, pages 367-371.
Crossref
Crossref
Futoshi Nagasaki, Hirofumi Niitsuma, Yoshiyuki Ueno, Jun Inoue, Takayuki Kogure, Koji Fukushima & Tooru Shimosegawa. (2007) The High Incidence of the Emergence of Entecavir-Resistant Mutants among Patients Infected with Lamivudine-Resistant Hepatitis B Virus. The Tohoku Journal of Experimental Medicine 213:2, pages 181-186.
Crossref
Crossref
Hee-Yeon Woo, Hyosoon Park, Byung-Ik Kim, Woo-Kyu Jeon, Yong Kyun Cho & Young Jae Kim. (2007) Comparison of Mass Spectrometric Analysis and TRUGENE™ HBV Genotyping for Monitoring Lamivudine Resistance in Chronic Hepatitis B Patients. Antiviral Therapy 12:1, pages 7-14.
Crossref
Crossref
Marc Bourlière. (2006) Perspectives et stratégies futures dans la prise en charge de la résistance aux analogues antiviraux dans le traitement de l’hépatite chronique B. Gastroentérologie Clinique et Biologique 30:10, pages 34-36.
Crossref
Crossref
Jean-Pierre Zarski. (2006) Prise en charge de la r?sistance aux analogues antiviraux chez un patient atteint de cirrhose d?compens?e. Gastroent?rologie Clinique et Biologique 30:10, pages 20-21.
Crossref
Crossref
Hyung Joon Yim, Munira Hussain, Ying Liu, Stephen N. Wong, Scott K. Fung & Anna S. F. Lok. (2006) Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology 44:3, pages 703-712.
Crossref
Crossref
Chien-Hung Chen, Jing-Houng Wang, Chuan-Mo Lee, Chao-Hung Hung, Tsung-Hui Hu, Jyh-Chwan Wang, Sheng-Nan Lu & Chi-Sin Changchien. (2005) Virological Response and Incidence of Adefovir Resistance in Lamivudine-Resistant Patients Treated with Adefovir Dipivoxil. Antiviral Therapy 11:6, pages 771-778.
Crossref
Crossref
Y.-F. Liaw, C.-M. Lee, R.-N. Chien & C.-T. Yeh. (2006) Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis. Journal of Viral Hepatitis 13:4, pages 250-255.
Crossref
Crossref
Chang Hong Lee, Soo–Ok Kim, Kwan Soo Byun, Myung Soon Moon, Eun–Ok Kim, Jong Eun Yeon, Wangdon Yoo & Sun Pyo Hong. (2006) Predominance of Hepatitis B Virus YMDD Mutants Is Prognostic of Viral DNA Breakthrough. Gastroenterology 130:4, pages 1144-1152.
Crossref
Crossref
Jung Woo Shin. (2006) Clinical significance of hepatitis B e antigen level easurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive. World Journal of Gastroenterology 12:41, pages 6693.
Crossref
Crossref
Rui Wang. (2006) Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata. World Journal of Gastroenterology 12:25, pages 4038.
Crossref
Crossref
Hidetaka Shibata, Tatsuki Ichikawa, Kazuhiko Nakao, Yasuhide Motoyoshi, Hiroshi Kawashimo, Mariko Fukuta, Takashi Goto, Naota Taura, Daisuke Nishimura, Keisuke Hamasaki, Kazuaki Okubo & Katsumi Eguchi. (2006) A fatal case of severe acute exacerbation due to hepatitis B virus with YMDD motif mutation. Kanzo 47:7, pages 329-333.
Crossref
Crossref
Volker Eckert & Wilhelm G. Struff. (2006) Hepatitis B: Where Are We Today?. Transfusion Medicine and Hemotherapy 33:5, pages 441-452.
Crossref
Crossref
Yun‐Fan Liaw. 2005. Viral Hepatitis. Viral Hepatitis
337
344
.
Hyon-Suk Kim, Kwang-Hyub Han, Sang Hoon Ahn, Eun-Ok Kim, Hye-Young Chang, Myoung Soon Moon, Hyun Jae Chung, Wangdon Yoo, Soo-Ok Kim & Sun Pyo Hong. (2005) Evaluation of Methods for Monitoring Drug Resistance in Chronic Hepatitis B Patients during Lamivudine Therapy Based on Mass Spectrometry and Reverse Hybridization. Antiviral Therapy 10:3, pages 441-449.
Crossref
Crossref
M. Natsuizaka, S. Hige, Y. Ono, K. Ogawa, M. Nakanishi, M. Chuma, S. Yoshida & M. Asaka. (2005) Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region. Journal of Viral Hepatitis 12:2, pages 154-159.
Crossref
Crossref
Jian Sun, Zhanhui Wang, Shiwu Ma, Guobing Zeng, Zhiyong Zhou, Kangxian Luo & Jinlin Hou. (2005) Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: A single center experience. Journal of Medical Virology 75:3, pages 391-398.
Crossref
Crossref
Zhong-Min Huang. (2005) YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines. World Journal of Gastroenterology 11:6, pages 867.
Crossref
Crossref
STEPHEN A LOCARNINI & TIM SHAW. (2004) Antiviral drug resistance in hepatitis B and C. Journal of Gastroenterology and Hepatology 19:s7, pages S322-S328.
Crossref
Crossref
STEPHEN LOCARNINI. (2004) Relevance of HBV mutations in severity and progression of chronic hepatitis B. Journal of Gastroenterology and Hepatology 19:s7, pages S108-S112.
Crossref
Crossref
Chien-Hung Chen, Chuan-Mo Lee, Sheng-Nan Lu, Jing-Houng Wang, Hung-Da Tung, Chao-Hung Hung, Wei-Jen Chen & Chi-Sin Changchien. (2004) Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants. Journal of Hepatology 41:3, pages 454-461.
Crossref
Crossref
Sun Pyo Hong, Nam Keun Kim, Seong Gyu Hwang, Hyun Jae Chung, Sukjoon Kim, Jin Hee Han, Hyung Tae Kim, Kyu Sung Rim, Myung Seo Kang, Wangdon Yoo & Soo-Ok Kim. (2004) Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. Journal of Hepatology 40:5, pages 837-844.
Crossref
Crossref
Yun-Fan Liaw, Rong-Nan Chien & Chau-Ting Yeh. (2004) No Benefit to Continue Lamivudine Therapy after Emergence of Ymdd Mutations. Antiviral Therapy 9:2, pages 257-262.
Crossref
Crossref
Peter Angus & Stephen Locarnini. (2004) Lamivudine-Resistant Hepatitis B Virus and Ongoing Lamivudine Therapy: Stop the Merry-Go-Round, It'S Time to get off!. Antiviral Therapy 9:2, pages 145-148.
Crossref
Crossref
Pilar Le?n, Francisco Pozo & Jos? M. Echevarr?a. (2004) Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain. Enfermedades Infecciosas y Microbiolog?a Cl?nica 22:3, pages 133-137.
Crossref
Crossref
Ryukichi Kumashiro, Reiichiro Kuwahara, Tatsuya Ide, Yuriko Koga, Teruko Arinaga, Akiko Hisamochi, Kei Ogata, Kazuo Tanaka & Michio Sata. (2003) Subclones of Drug-Resistant Hepatitis B Virus Mutants and the Outcome of Breakthrough Hepatitis in Patients Treated with Lamivudine. Intervirology 46:6, pages 350-354.
Crossref
Crossref
Chuan-Mo Lee, Guan-Yeow Ong, Sheng-Nan Lu, Jing-Houng Wang, Chun-Ann Liao, Hung-Da Tung, Tsung-Ming Chen & Chi-Sin Changchien. (2002) Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation. Journal of Hepatology 37:5, pages 669-674.
Crossref
Crossref